Brightflow, a Paris, France-based medical device company, raised €16.5M in Series A funding.
The round was led by new investors VIVES Partners, Majycc Innovation Santé – UI Investissement, BNP Paribas Development and international business angels, with participation from the existing syndicate of GO Capital and Karista.
The company intends to use the funds to accelerate its major strategic initiatives through to early 2026, including completion of product development and first implantations of its percutaneous right ventricular assist device.
Led by CEO Sophie Humbert, Brightflow is a medical device company which operates in the field of long-term percutaneous mechanical circulatory support to treat end-stage heart failure patients. The team’s vision is to bring to market the first long-term mechanical assist device to support RV failure without the need for open-heart surgery.
FinSMEs
10/09/2024